510(k) Report

510(k) · Cleared

Cleared

PF4 IgG assay

K201311510(k) SpecialCleared Jun 18, 202031-day reviewClass II21 CFR 864.7695

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Immucor Gti Diagnostics, Inc. · LCO Platelet Factor 4 Radioimmunoassay

Cleared on Jun 18, 2020 as substantially equivalent to K071781 (Genetic Testing Institute, 2007) after a 31-day review. Its family tree reaches back 3 generations to 1999.

Decided
Jun 18, 2020
Review
31 days
Class
Class II
Product code
LCO
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K983379 (1999). No later device cites it as a predicate yet.

  1. Root · 3 generations backK983379 Gti-PF4 ElisaGenetic Testing Institute · 1999
  2. 2 generations backK053559 PF4 Enhanced Solid Phase ElisaGenetic Testing Institute · 2006 · Recalled
  3. 1 generation backK071781 PF4 IGGGenetic Testing Institute · 2007
  4. This deviceK201311 PF4 IgG assayImmucor Gti Diagnostics, Inc. · 2020
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K983379Gti-PF4 ElisaGenetic Testing Institute1999—
−2K053559PF4 Enhanced Solid Phase ElisaGenetic Testing Institute20062
−1K071781PF4 IGGGenetic Testing Institute2007—
0 (this device)K201311PF4 IgG assayImmucor Gti Diagnostics, Inc.2020—
FIG. 1 — Lineage of K201311, 1999–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LCO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LCO device

  1. #1 K243374 HemosIL CL HIT-IgG (PF4-H)score 9.7 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K071781PF4 IGG
Summary page 4
…oduct Code: LCO Establishment Registration Number: 2183608 3. Name of Predicate Device for Claiming Equivalence PF4 IgG (K071781) 4. Description of Device PF4 IgG assay is an enzyme linked immunosorbent assay (ELISA). The PF4 IgG ELISA is int…
Genetic Testing Institute2007—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 2 companies; a new generation was cleared every 6.9 years on median.
  • 1 of the 3 ancestors has a recall of any class.

How does its category compare?

All LCO devices

LCO Platelet Factor 4 Radioimmunoassay: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · LCO

1in 2025

2007: 22016: 12017: 12020: 22025: 1
2007high 2 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LCO

Too few LCO 510(k)s in any year since 2007 to give a median.

Recalls per year · LCO

3so far in 2026, the most since 2007

2011: 22013: 12014: 12026 (partial year): 3, 2 Class I
2007high 3 (2026) · low 0 (2007)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · LCO

11in 2025

2016: 22019: 42020: 12024: 22025: 11
2007high 11 (2025) · low 0 (2007)2025

MAUDE reports naming product code LCO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20080—00
20090—00
20100—00
20110—20
20120—00
20130—10
20140—10
20150—00
20161—02
20171—00
20180—00
20190—04
20202—01
20210—00
20220—00
20230—00
20240—02
20251—011
20260—3 (2)—

What is it indicated for?

PF4 IgG assay is a qualitative screening assay for the detection of heparin associated IgG antibodies in human serum or plasma. The presence of heparin-associated antibodies are commonly found in patients with Heparin Induced Thrombocytopenia (HIT).

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K201311: PF4 IgG assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K201311

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026